(Q39413392)

11 September 2017

title

Lack of symptom benefit following presumptive Helicobacter pylori eradication therapy in primary care (English)

1 reference

Helicobacter pylori infectious disease

11 September 2017

0 references

1 reference

Williams D

1

1 reference

11 September 2017

O'Kelly P

series ordinal

2

1 reference

11 September 2017

Kelly A

series ordinal

3

1 reference

11 September 2017

Feely J

series ordinal

4

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Alimentary Pharmacology & Therapeutics

11 September 2017

published in

1 reference

11 September 2017

volume

15

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

1769-1775

1 reference

Prevalence of symptoms of dyspepsia in the community

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Relation between Helicobacter pylori infection and gastrointestinal symptoms and syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Eradication of Helicobacter pylori and non-ulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

The influence of hospital-based prescribers on prescribing in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Eradication of Helicobacter pylori in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Regular review: treatment of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Challenges in managing dyspepsia in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Management of dyspepsia in primary care. GPs are already choosing eradication therapy over endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Helicobacter pylori, gastric acid, and duodenal gastric metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.01100.X

10.1046/J.1365-2036.2001.01100.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference